James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $538.52 ($5.5M) on 2026-06-15, disclosed to the SEC on 2026-06-16.
Scheduled sale ($5.5M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $538.52 | 121 | $65K | 1.2% |
| 2 | $539.46 | 74 | $40K | 0.7% |
| 3 | $540.64 | 45 | $24K | 0.4% |
| 4 | $541.61 | 240 | $130K | 2.4% |
| 5 | $543.50 | 560 | $304K | 5.5% |
| 6 | $545.63 | 855 |
| $467K |
| 8.5% |
| 7 | $546.54 | 504 | $275K | 5.0% |
| 8 | $547.77 | 465 | $255K | 4.6% |
| 9 | $548.64 | 1,616 | $887K | 16.1% |
| 10 | $549.87 | 800 | $440K | 8.0% |
| 11 | $550.89 | 2,200 | $1.2M | 22.1% |
| 12 | $551.91 | 1,144 | $631K | 11.5% |
| 13 | $553.10 | 778 | $430K | 7.8% |
| 14 | $553.76 | 598 | $331K | 6.0% |
| Total | $549.17 avg | 10,000 | $5.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-05 | $5.5M | — | Filing → |